Trastornos del sueño y condiciones ambientales en mayores de 65 años

Gras, Clotilde Boix; Hidalgo, Jesús Dativo López-Torres; García, Yolanda David; Lapeira, Juan Manuel Téllez; Ferrer, Alejandro Villena; Martínez, Ignacio Párraga

doi:10.1016/j.aprim.2008.11.015

Cited by 10 publications

(1 citation statement)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Difficulty sleeping is common in older adults and is frequently attributed to changes that age causes in sleep architecture. However, these changes do not necessarily imply sleep disturbances and lead to insomnia (Gras et al, 2009). As in other studies (Patel et al, 2018), our results show a high prevalence of insomnia symptoms in those over 60 years of age who live in the community, where 41.5% of the participants presented symptoms of insomnia.…”

Section: Discussionmentioning

confidence: 99%

Salivary Interleukin 1-Beta Concentration Associates With Sleep Quality in Older Individuals

Valle

Ballestar-Tarín

Mafla-España

et al. 2023

Biological Research For Nursing

View full text Add to dashboard Cite

Background: Poor sleep quality is prevalent in older people and impairs their quality of life. Various studies show an association between sleep disorders and altered levels of inflammatory cytokines. The cytokine IL-1β has been shown to display both somnogenic and insomnia-promoting effects in experimental animals. Objectives: to evaluate the relationship between insomnia and salivary IL-1β concentration and the role of associated factors such as the symptoms of depression, use of hypnotics, intake of caffeinated beverages, smoking, and alcohol use in older individuals. An analytical, cross-sectional, observational research was carried out with a population of community-dwelling individuals over 60 years of age in Valencia (Spain). Sleep quality was measured with the Athens insomnia scale (AIS) and depressive symptoms with Geriatric Depression Scale (GDS). Results: 287 individuals participated in the study (mean age 74.08 years (76.7% women). 41.5% of the participants had insomnia, 36.9% took drugs for sleep problems, and 32.4% had relevant depressive symptoms. There was a significant inverse correlation between the IL-1β and total AIS score (rho = −0.302, p < 0.001), the sleep difficulty subdomain (rho = −0.259, p < 0.001), and the daytime sleepiness subdomain (rho = −0.322, p < 0.001). No significant correlation was observed between GDS and salivary IL-1β concentration. The IL-1β concentration was significantly lower in individuals taking drugs for sleeping compared with those not taking those drugs (1.11 ± 0.09 and 1.48 ± 0.08, respectively; p = 0.001). Regarding the AIS score, there was no significant difference in marital status, smoking, or the number of cups of tea or cola drinks, but there was a significant association with alcohol intake ( p = 0.019) and in the number of daily intakes of coffee ( p = 0.030). The receiver operating characteristic (ROC) curve analysis of IL-1β for diagnosis of moderate-severe insomnia showed an area under the curve (AUC) value of 0.78 (95% confidence interval 0.71–0.85). At the cut-off of 0.83 pg/µL of Il-1β, it had a sensitivity of 70.3% and a specificity of 69.8%.

show abstract

Section: Discussionmentioning

confidence: 99%